Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Tirzepatide does not directly worsen celiac disease, but its gastrointestinal side effects (nausea, diarrhea, abdominal discomfort) may overlap with celiac symptoms, particularly in patients with active disease or incomplete mucosal healing
Its important to drink plenty of water and stay hydrated
Introduced by Eli Lilly in August 2024 in response to high demand and access barriers, Zepbound single-dose vials make it possible to receive the same active ingredient that produced up to 21% mean body weight loss in clinical trials at prices starting at $299 per month compared to a list price of over $1,086 for the autoinjector pen version
The findings have not been replicated in robust controlled studies
Preclinical research has demonstrated these mechanisms extensively, though human clinical trials specific to IGF-1 LR3 are still limited
PMID: 40506769
US$ 24.17
US$ 20.13
US$ 27.33
US$ 23.02
US$ 26.05
